1 active not recruiting, 1 recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Medroxyprogesterone Acetate 500 MG: new trials by email Literature Review of Medroxyprogesterone Acetate 500 MG trials Research Report on Medroxyprogesterone Acetate 500 MG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification PD1 antibody, Medroxyprogesterone Acetate 500 MG, Megestrol Acetate 160 MG - Endometrial Cancer, Fertility | Phase 2 / Phase 3 | Recruiting | Fudan University | 260 | 2026-01-25 | 2026-03-13 |
| Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer Megestrol Acetate 160 MG Oral Tablet, Medroxyprogesterone Acetate 500 MG, Triprorelin Acetate - Endometrial Neoplasm Malignant Stage I | Phase 2 | Active not recruiting | Fudan University | 104 | 2022-03-11 | 2026-10-23 |
Fudan University (2)
China (2)